Gilead Sciences Beats Street and Sees Sovaldi Sales Double - Presented by: The Aol. On Network

Gilead Sciences shares rose sharply in after-hours trading on Wednesday after the company reported second quarter results which surpassed analyst forecasts. The biotech company posted profits of $2.23 a share, far higher than the $1.79 analysts had been expecting. Revenue came in at $6.53 billion, that was also better than estimates. Gilead reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago because of its Sovaldi sales. Sovaldi



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.365 0.02 ▲ 0.09%
AAPL $ 125.14 0.66 ▼ 0.52%
VALE $ 8.6399 0.16 ▼ 1.82%
NOK $ 6.46 0.08 ▲ 1.25%
CHK $ 14.94 0.92 ▼ 5.80%
PBR $ 10.08 0.11 ▼ 1.08%
MSFT $ 46.77 0.83 ▼ 1.74%
QQQ $ 107.05 0.40 ▼ 0.37%

As of 5/6/2015, 11:41 AM